OncoSec Medical Inc (ONCSQ)

[hschlauch]

I'm afraid so. They have been talking about additional intratumoral DNA constructs for quite some time, but there simply hasn't been anything definitive. Why have they stalled out? What proteins will be expressed for these other agents and what are the indications? No one knows much of anything about their preclinical pipeline. They have been so laser focused on the PISCES phase 2 trial that they have lost sight of investor perception. NO INVESTOR IS GOING TO RISK MUCH MONEY ON A POSSIBLE ONE TRICK PONY. They need to simultaneously advance their preclinical pipeline - right now, it doesn't appear to exist. And Punit goes to these conferences just glossing over the early stage work. Is there a pipeline or not?